Vice President, Biomarker and BioAnalytical Sciences
Sangamo Therapeutics, Inc
Richmond, California
-Dr. Yanmei Lu is currently the Vice President of Biomarker and BioAnalytical Sciences at Sangamo Therapeutics. Her group supports gene and cell therapy programs at both preclinical and clinical stages:
Biomarker discovery
Biomarker strategy
Bioanalysis
Companion diagnostic development
-Dr. Lu holds a PhD in Biochemistry and Molecular Biology from University of South Florida and has published over 50 peer-reviewed articles/book chapters
Disclosure information not submitted.
Companion Diagnostics for AAV-Mediated Gene Therapy: Recent Developments and Challenges
Thursday, May 16, 2024
10:00 AM – 10:30 AM PT